Jayaprakash D. Karkera

Author

Also Known As

J D Karkera, J Karkera, J. D. Karkera, J. Karkera, J.D. Karkera, Jayaprakash D Karkera, Jayaprakash D. Karkera, Jayaprakash Karkera

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

National Institutes of Health National Human Genome Research Institute National Institute of Mental Health Children's Hospital of Philadelphia Baylor College of Medicine

About

Jayaprakash D. Karkera is an author at National Institutes of Health specializing in medicine, genetics, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	1.5K
2	Cell Biology	5	5	247
3	Natural Sciences	1	1	51
4	Public Health	1	1	390
5	Social Sciences	1	1	291

Jayaprakash D. Karkera

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
A high-density genome scan detects evidence for a bipolar-disorder susceptibility locus on 13q32 and other potential loci on 1q32 and 18p11.2 Sevilla D. Detera‐Wadleigh, Judith A. Badner, Wade H. Berrettini, Proceedings of the National Academy of Sciences GeneticsGenetic EpidemiologyLinkage AnalysisDisease Gene IdentificationGenomics	1999	390
Discovery and Pharmacological Characterization of JNJ-42756493 (Erdafitinib), a Functionally Selective Small-Molecule FGFR Family Inhibitor Timothy Perera, Eleonora Jovcheva, Laurence Mévellec, Molecular Cancer Therapeutics	2017	335
A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication Mauricio Arcos‐Burgos, Mahim Jain, Maria T. Acosta, Molecular Psychiatry AdhdPsychiatryPsychotropic MedicationPsychopharmacologyStimulant Medication	2010	291
CFC1 Mutations in Patients with Transposition of the Great Arteries and Double-Outlet Right Ventricle Elizabeth Goldmuntz, Richard N. Bamford, Jayaprakash D. Karkera, The American Journal of Human Genetics CardiomyopathyCardiovascular DiseaseGeneticsCfc1 MutationsPathology	2002	204
Reduced NODAL Signaling Strength via Mutation of Several Pathway Members Including FOXH1 Is Linked to Human Heart Defects and Holoprosencephaly Erich Roessler, Maia V. Ouspenskaia, Jayaprakash D. Karkera, The American Journal of Human Genetics Transcriptional RegulationDevelopmental BiologyNodal Signaling StrengthSignaling PathwayGenetic Disorder	2008	174
Novel mutation in sonic hedgehog in non‐syndromic colobomatous microphthalmia Lisa A. Schimmenti, June de la Cruz, Richard A. Lewis, American Journal of Medical Genetics Part A	2002	156
Molecular cytogenetic fingerprinting of esophageal squamous cell carcinoma by comparative genomic hybridization reveals a consistent pattern of chromosomal alterations Svetlana Pack, Jayaprakash D. Karkera, Zhengping Zhuang, Genes Chromosomes and Cancer	1999	150
Loss-of-Function Mutations in Growth Differentiation Factor-1 (GDF1) Are Associated with Congenital Heart Defects in Humans Jayaprakash D. Karkera, J.S. Lee, Erich Roessler, The American Journal of Human Genetics Heart FailureDevelopmental BiologyCardiac ReprogrammingGeneticsLoss-of-function Mutations	2007	137
The anti‐interleukin‐6 antibody siltuximab down‐regulates genes implicated in tumorigenesis in prostate cancer patients from a phase I study Jayaprakash D. Karkera, Hannes Steiner, Weimin Li, The Prostate	2011	111
Cumulative ligand activity of NODAL mutations and modifiers are linked to human heart defects and holoprosencephaly Erich Roessler, Wuhong Pei, Maia V. Ouspenskaia, Molecular Genetics and Metabolism CardiomyopathyMolecular PhysiologyGenetic DisorderGeneticsHuman Heart Defects	2009	73

Page 1